REPROS THERAPEUTICS INC. Retained Earnings
REPROS THERAPEUTICS INC. had Retained Earnings of -$329.25 million as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-11-13
- 2017-09-30: Retained Earnings (Accumulated Deficit) -$329.25M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$327.64M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$325.44M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$319.53M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-09-30 | -$329.25M 10-Q · filed 2017-11-13 |
| 2017-06-30 | -$327.64M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$325.44M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$319.53M 10-Q · filed 2017-11-13 |
| 2016-09-30 | -$315.55M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$311.38M 10-Q · filed 2016-08-09 |
| 2016-03-31 | -$307.10M 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$302.26M 10-K · filed 2017-03-31 |
| 2015-09-30 | -$295.99M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$289.38M 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$281.59M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$273.06M 10-K · filed 2016-03-14 |
| 2013-12-31 | -$240.53M 10-Q · filed 2015-11-09 |
| 2012-12-31 | -$212.06M 10-K · filed 2015-03-16 |
| 2011-12-31 | -$193.12M 10-K · filed 2015-03-16 |